"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
Radiogardase Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Radiogardase (insoluble prussian blue) is used to treat people who have been contaminated with radioactive cesium or thallium, or non-radioactive thallium. It works by binding to the metals in the digestive tract to keep the body from absorbing them. Common side effects include constipation or stomach discomfort.
The recommended dose of Radiogardase insoluble for adults and adolescents is 3 grams orally three times a day. The recommended pediatric dose is 1 gram orally three times a day. Radiogardase may interact with other drugs. Tell your doctor all medications and supplements you use. Radiogardase may be harmful to a fetus. Tell your doctor if you are pregnant before you are treated with Radiogardase. It is unknown if this drug passes into breast milk or if it could harm a nursing baby. Consult your doctor before breastfeeding.
Our Radiogardase (insoluble prussian blue) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information in Detail?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Radiogardase in Detail - Patient Information: Side Effects
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your caregivers at once if you have a serious side effect such as severe constipation or stomach pain.
Less serious side effects may include mild constipation or minor stomach discomfort.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Radiogardase (Insoluble Prussian blue)
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Radiogardase FDA Prescribing Information: Side Effects
Deaths or serious or severe adverse events attributed to Prussian blue insoluble have not been reported. Constipation was reported in 10/42 (24%) patients in the Goiânia accident treated with Prussian blue insoluble. Severity of constipation was mild in 7 patients and moderate in 3 patients. Constipation was successfully treated with a high fiber diet.
Undefined gastric distress was reported in 3 patients treated with 20 gram/day of Prussian blue insoluble. In these patients the dose was reduced to 10 gram/day for continued treatment.
Read the entire FDA prescribing information for Radiogardase (Insoluble Prussian blue)
Additional Radiogardase Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.